Literature DB >> 16630523

Management of the complications of external beam radiotherapy and brachytherapy.

Stacy Loeb1, Robert B Nadler.   

Abstract

External beam radiation therapy (EBRT) and brachytherapy are common treatment modalities for newly diagnosed prostate cancer. What complications can patients and physicians expect following these therapies? How are these conditions diagnosed and treated? In this article, we examine several of the most common acute and delayed complications of radiation therapy for prostate cancer. In addition, we discuss appropriate follow-up diagnostics for these patients and our suggestions for management of the main complications that may develop.

Entities:  

Mesh:

Year:  2006        PMID: 16630523     DOI: 10.1007/s11934-006-0022-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  45 in total

1.  Postirradiation sarcoma after external beam radiation therapy for localized adenocarcinoma of the prostate: report of three cases.

Authors:  M McKenzie; I MacLennan; E Kostashuk; T Bainbridge
Journal:  Urology       Date:  1999-06       Impact factor: 2.649

2.  Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitis.

Authors:  Kian Tai Chong; Neil B Hampson; David G Bostwick; Robert L Vessella; John M Corman
Journal:  BJU Int       Date:  2004-12       Impact factor: 5.588

3.  Evolution of techniques for ultrasound-guided palladium 103 brachytherapy in 950 patients with prostate cancer.

Authors:  J Sharkey; S D Chovnick; R J Behar; R Perez; J Otheguy; R Rabinowitz; Z Solc; W Huff; A Cantor; J Steele; C Webster; M Donohue
Journal:  Tech Urol       Date:  2000-06

4.  Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization.

Authors:  Rosemonde Woel; Clair Beard; Ming-Hui Chen; Mark Hurwitz; Marian Loffredo; Elizabeth McMahon; Jane Ching; Lynn Lopes; Anthony V D'Amico
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

5.  The dosimetry of prostate brachytherapy-induced urethral strictures.

Authors:  Gregory S Merrick; Wayne M Butler; Bryan G Tollenaar; Robert W Galbreath; Jonathan H Lief
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

6.  Rectal complications after prostate brachytherapy.

Authors:  Shimul A Shah; Robert R Cima; Eric Benoit; Elizabeth L Breen; Ronald Bleday
Journal:  Dis Colon Rectum       Date:  2004-08-12       Impact factor: 4.585

7.  High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.

Authors:  Inga S Grills; Alvaro A Martinez; Mitchell Hollander; Raywin Huang; Kenneth Goldman; Peter Y Chen; Gary S Gustafson
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Hazards of dose escalation in prostate cancer radiotherapy.

Authors:  Deborah Kuban; Alan Pollack; Eugene Huang; Larry Levy; Lei Dong; George Starkschall; Isaac Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

9.  Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.

Authors:  Michael J Zelefsky; Jennifer Moughan; Jean Owen; Anthony L Zietman; Mack Roach; Gerald E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

10.  Time course and predictors of symptoms after primary prostate cancer therapy.

Authors:  James A Talcott; Judithy Manola; Jack A Clark; Irving Kaplan; Clair J Beard; Sonya P Mitchell; Ronald C Chen; Michael P O'Leary; Philip W Kantoff; Anthony V D'Amico
Journal:  J Clin Oncol       Date:  2003-11-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.